Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Negative social impacts among volunteers in an HIV vaccine efficacy trial.
Fuchs J, Durham M, McLellan-Lemal E, Vittinghoff E, Colfax G, Gurwith M, Buchbinder S. Fuchs J, et al. Among authors: gurwith m. J Acquir Immune Defic Syndr. 2007 Nov 1;46(3):362-8. doi: 10.1097/QAI.0b013e3181565dcb. J Acquir Immune Defic Syndr. 2007. PMID: 17721399
Motivations for participating in an HIV vaccine efficacy trial.
Colfax G, Buchbinder S, Vamshidar G, Celum C, McKirnan D, Neidig J, Koblin B, Gurwith M, Bartholow B. Colfax G, et al. Among authors: gurwith m. J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):359-64. doi: 10.1097/01.qai.0000152039.88422.ec. J Acquir Immune Defic Syndr. 2005. PMID: 15980699 Clinical Trial.
Demographic and behavioral contextual risk groups among men who have sex with men participating in a phase 3 HIV vaccine efficacy trial: implications for HIV prevention and behavioral/biomedical intervention trials.
Bartholow BN, Goli V, Ackers M, McLellan E, Gurwith M, Durham M, Greenberg AE. Bartholow BN, et al. Among authors: gurwith m. J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):594-602. doi: 10.1097/01.qai.0000243107.26136.82. J Acquir Immune Defic Syndr. 2006. PMID: 17003693
Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial.
Gilbert PB, Peterson ML, Follmann D, Hudgens MG, Francis DP, Gurwith M, Heyward WL, Jobes DV, Popovic V, Self SG, Sinangil F, Burke D, Berman PW. Gilbert PB, et al. Among authors: gurwith m. J Infect Dis. 2005 Mar 1;191(5):666-77. doi: 10.1086/428405. Epub 2005 Jan 27. J Infect Dis. 2005. PMID: 15688279 Clinical Trial.
Blood and seminal plasma HIV-1 RNA levels among HIV-1-infected injecting drug users participating in the AIDSVAX B/E efficacy trial in Bangkok, Thailand.
Kittikraisak W, van Griensven F, Martin M, McNicholl J, Gilbert PB, Chuachoowong R, Vanichseni S, Sutthent R, Tappero JW, Mastro TD, Hu DJ, Gurwith M, Kitayaporn D, Sangkum U, Choopanya K. Kittikraisak W, et al. Among authors: gurwith m. J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):601-8. doi: 10.1097/QAI.0b013e3181a44700. J Acquir Immune Defic Syndr. 2009. PMID: 19430307 Free PMC article. Clinical Trial.
Drug use and the risk of HIV infection amongst injection drug users participating in an HIV vaccine trial in Bangkok, 1999-2003.
Martin M, Vanichseni S, Suntharasamai P, Mock PA, van Griensven F, Pitisuttithum P, Tappero JW, Chiamwongpaet S, Sangkum U, Kitayaporn D, Gurwith M, Choopanya K; Bangkok Vaccine Evaluation Group. Martin M, et al. Among authors: gurwith m. Int J Drug Policy. 2010 Jul;21(4):296-301. doi: 10.1016/j.drugpo.2009.12.002. Epub 2010 Jan 15. Int J Drug Policy. 2010. PMID: 20079620 Clinical Trial.
141 results